Galmed Pharmaceuticals (GLMD) Current Assets (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Current Assets of $16.0 million for Q1 2026, down 1.66% year-over-year from $16.3 million in Q1 2025, and down 13.96% quarter-over-quarter from $18.6 million in Q4 2025.
Galmed Pharmaceuticals (GLMD) Current Assets (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Current Assets history runs 14 years deep, the most recent figure standing at $16.0 million for Q1 2026.
- In Q1 2026, Current Assets fell 1.66% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (down 1.66% YoY), while the FY2025 annual figure was $18.6 million, up 2933.71% from the prior year.
- Current Assets for Q1 2026 stood at $16.0 million, down from $18.6 million in the prior quarter.
- The five-year high for Current Assets was $29.7 million in Q1 2022, with the low at $5000.0 in Q1 2023.
- The 5-year median for Current Assets is $16.0 million (2026), against an average of $15.1 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 99.98% in 2023, then jumped 223540.0% in 2024.
- Galmed Pharmaceuticals' Current Assets stood at $14.7 million in 2022, then slipped by 10.09% to $13.2 million in 2023, then tumbled by 95.36% to $614000.0 in 2024, then surged by 2933.71% to $18.6 million in 2025, then dropped by 13.96% to $16.0 million in 2026.
- Business Quant data shows GLMD's Current Assets at $16.0 million in Q1 2026, $18.6 million in Q4 2025, and $19.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 1.76 Bn |
| 10 | Galmed Pharmaceuticals | 2.30 Mn | -9.58 Mn | - | 16.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.03 Mn |
| Dec 31, 2025 | 18.63 Mn |
| Sep 30, 2025 | 19.72 Mn |
| Jun 30, 2025 | 21.08 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 17.69 Mn |
| Jun 30, 2024 | 10.08 Mn |
| Mar 31, 2024 | 11.18 Mn |
| Dec 31, 2023 | 13.24 Mn |
| Sep 30, 2023 | 14.20 Mn |
| Jun 30, 2023 | 9.79 Mn |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 14.72 Mn |
| Sep 30, 2022 | 20.48 Mn |
| Jun 30, 2022 | 23.13 Mn |
| Mar 31, 2022 | 29.70 Mn |
| Dec 31, 2021 | 36.05 Mn |
| Sep 30, 2021 | 43.69 Mn |
| Jun 30, 2021 | 51.67 Mn |